Treponema pallidum subspecies pallidum is the causative agent of syphilis, a sexually transmitted infection (STI).
| Test Name and Number | Recommended Use | Limitations | Follow Up |
|---|---|---|---|
| Treponema pallidum (Rapid Plasma Reagin) with Reflex to Titer 0050471 Method: Semi-Quantitative Charcoal Agglutination |
Initial screening test for syphilis Follow treatment response |
False positives may be caused by HIV, herpes simplex virus (HSV), malaria, intravenous drug use (IVDU), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), pregnancy, leprosy, endemic treponematoses |
|
| Treponema pallidum (VDRL), Serum with Reflex to Titer 0093093 Method: Semi-Quantitative Flocculation |
Alternative initial screening test for syphilis |
Use rapid plasma reagin (RPR) preferentially to decrease false-positive rate False positives may be caused by HIV, HSV, malaria, IVDU, SLE, RA, pregnancy, leprosy, endemic treponematoses |
|
| Treponema pallidum Antibody by TP-PA 0050777 Method: Semi-Quantitative Particle Agglutination |
Confirm reactive screening nontreponemal test in suspected syphilis Resolve inconclusive FTA-Abs results |
Cannot differentiate between IgG and IgM antibodies Compares favorably to FTA test but slightly less sensitive in untreated early primary syphilis Cannot be tested with CSF Do not use assay for blood donor screening or associated re-entry protocols |
|
| Treponema pallidum Antibody (FTA-ABS), Serum, IgG by IFA with Reflex to Treponema pallidum Antibody by TP-PA 0050477 Method: Semi-Quantitative Indirect Fluorescent Antibody/Semi-Quantitative Particle Agglutination |
Confirm reactive screening nontreponemal test in suspected syphilis Confirm inconclusive results from Treponema pallidum (VDRL) Resolve discrepancies between laboratory results and clinical impressions |
FTA tests for syphilis may be false positive in autoimmune disease, leprosy, febrile illnesses, advanced age, Lyme disease and endemic treponematoses May be helpful in late neurosyphilis when RPR is negative but high clinical suspicion for disease FTA antibody testing will usually remain reactive despite adequate therapy; do not use to monitor therapy Do not use assay for blood donor screening or associated re-entry protocols |
|
| Treponema pallidum Antibody, IgM by ELISA 0050921 Method: Semi-Quantitative Enzyme-Linked Immunosorbent Assay |
Discriminate maternally derived IgG antibodies that cross placenta from IgM antibodies that indicate active infection in the newborn Confirm congenital syphilis Highly specific (100%) and sensitive (91%) test |
Congenital syphilis – sensitivity is ~80%; therefore, negative IgM does not rule out congenital syphilis |
|
| Treponema pallidum Antibody, IgG by Immunoblot 2003095 Method: Qualitative Immunoblot |
Detect IgG antibodies against T. pallidum; useful as supplemental treponemal-based assay in cases where FTA-Abs results are inconclusive |
Do not use to determine relapse or reinfection of syphilis because of the persistence of reactivity, likely for life |
Repeat testing in 2-4 weeks is recommended if results are equivocal |